IGF-1-Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial Repair

被引:297
作者
Haider, Husnain Kh [1 ]
Jiang, Shujia [1 ]
Idris, Niagara M. [1 ]
Ashraf, Muhammad [1 ]
机构
[1] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
关键词
IGF-1; heart; myocardial infarction; SDF-1; alpha; stem cells;
D O I
10.1161/CIRCRESAHA.108.186742
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell-derived factor (SDF)-1 alpha. Rat bone marrow-derived MSCs were used as nontransduced ((MSCs)-M-Norm) or transduced with adenoviral-null vector ((MSCs)-M-Null) or vector encoding for IGF-1 (IGF-1MSCs). IGF-1MSCs secreted higher IGF-1 until 12 days of observation (P < 0.001 versus (MSCs)-M-Null). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl. xL and inhibition of glycogen synthase kinase 3 beta besides release of SDF-1 alpha in parallel with IGF-1 expression in IGF-1MSCs. For in vivo studies, 70 mu L of DMEM without cells (group 1) or containing 1.5 x 10(6) (MSCs)-M-Null (group 2) or IGF-1MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n = 4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of IGF-1MSCs (P < 0.06 versus (MSCs)-M-Null) (n = 6 per group). SDF-1 alpha was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit(+), MDR1(+), CD31(+), and CD34(+) cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P < 0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1 alpha signaling and culminated in extensive angiomyogenesis in the infarcted heart. (Circ Res. 2008; 103: 1300-1308.)
引用
收藏
页码:1300 / 1308
页数:9
相关论文
共 37 条
[1]   Increased level of pericardial insulin-like growth factor-1 in patients with left ventricular dysfunction and advanced heart failure [J].
Abe, Naoki ;
Matsunaga, Toshiro ;
Kameda, Kunihiko ;
Tomita, Hirofumi ;
Fujiwara, Takayuki ;
Ishizaka, Hiroshi ;
Hanada, Hiroyuki ;
Fukui, Kozo ;
Fukuda, Ikuo ;
Osanai, Tomohiro ;
Okumura, Ken .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) :1387-1395
[2]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[3]   CARDIOPROTECTIVE EFFECT OF INSULIN-LIKE GROWTH-FACTOR-I IN MYOCARDIAL-ISCHEMIA FOLLOWED BY REPERFUSION [J].
BUERKE, M ;
MUROHARA, T ;
SKURK, C ;
NUSS, C ;
TOMASELLI, K ;
LEFER, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :8031-8035
[4]   Strategic advantages of insulin-tike growth factor-1 expression for cardioprotection [J].
Chao, W ;
Matsui, T ;
Novikov, MS ;
Tao, JZ ;
Li, L ;
Liu, HL ;
Ahn, Y ;
Rosenzweig, A .
JOURNAL OF GENE MEDICINE, 2003, 5 (04) :277-286
[5]   Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat - A combined in vivo and in vitro evaluation [J].
Cittadini, A ;
Stromer, H ;
Katz, SE ;
Clark, R ;
Moses, AC ;
Morgan, JP ;
Douglas, PS .
CIRCULATION, 1996, 93 (04) :800-809
[6]   Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction [J].
Davis, Michael E. ;
Hsieh, Patrick C. H. ;
Takahashi, Tomosaburo ;
Song, Qing ;
Zhang, Shuguang ;
Kamm, Roger D. ;
Grodzinsky, Alan J. ;
Anversa, Piero ;
Lee, Richard T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (21) :8155-8160
[7]   INSULIN-LIKE GROWTH-FACTOR-I ENHANCES VENTRICULAR HYPERTROPHY AND FUNCTION DURING THE ONSET OF EXPERIMENTAL CARDIAC-FAILURE [J].
DUERR, RL ;
HUANG, S ;
MIRALIAKBAR, HR ;
CLARK, R ;
CHIEN, KR ;
ROSS, J .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :619-627
[8]   Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium [J].
Elmadbouh, I. ;
Haider, Husnain Kh ;
Jiang, Shujia ;
Idris, Niagara Muhammad ;
Lu, Gang ;
Ashraf, Muhammad .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (04) :792-803
[9]   A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function [J].
Giordano, FJ ;
Gerber, HP ;
Williams, SP ;
VanBruggen, N ;
Bunting, S ;
Ruiz-Lozano, P ;
Gu, YS ;
Nath, AK ;
Huang, Y ;
Hickey, R ;
Dalton, N ;
Peterson, KL ;
Ross, J ;
Chien, KR ;
Ferrara, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5780-5785
[10]   Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement [J].
Gnecchi, Massimiliano ;
He, Huamei ;
Noiseux, Nicolas ;
Liang, Olin D. ;
Zhang, Lunan ;
Morello, Fulvio ;
Mu, Hui ;
Melo, Luis G. ;
Pratt, Richard E. ;
Ingwall, Joanne S. ;
Dzau, Victor J. .
FASEB JOURNAL, 2006, 20 (06) :661-669